CANCER, GENOMICS AND CONSULTING LTD
Executive Summary
Cancer, Genomics and Consulting Ltd is a promising micro-sized enterprise leveraging a unique combination of medical, biotechnological, and IT consulting expertise to address emerging needs in precision oncology. Its strong financial footing and strategic location underpin growth potential through service expansion and partnerships, though scaling operational capacity and managing regulatory complexities remain critical challenges to ensure sustainable competitive advantage.
View Full Analysis Report →Financials
- Year ending
- 2024-06-30
- Total net assets
- £53.99k£39.10k vs previous year
- Total liabilities
- £-9.17k£-4.91k vs previous year
- Total assets
- £64.16k£44.00k vs previous year
Annual accounts
Financial Year Ending | |
---|---|
22 July 2024 | |
30 June 2024 | |
16 August 2023 | |
30 June 2023 | |
30 June 2022 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company